News About: Pharm. Industry
Choongwae Holdings wins 18 million euros deal in Russia
Choongwae Holdings Co., a Korean holding company, said on July 21 that it has signed an 18 million euro deal with Berlin Chemie in Russia to provide mutichamber products for TPN for six year, following its first expor...
Korea reinstates market approval of sibutramine
The Korean Food and Drug Administration said on July 20 it has concluded that the benefit/risk assessment of sibutramine is favorable and will its continued sale here after convening the Central Pharmaceutical Affairs...
Merck’s Januvia sales top 18.8 billion won in first half
The US based Merck’s Januvia has gained its momentum as its sales of its flagship model posted 18.8 billion won, up a whopping 189.2 percent from the same period of last year.
Januvia, a pill that was approved by ...
KMPA president prioritizes effective communication with government
New president of the Korea Pharmaceutical Manufacturers Association said on July 19 that the association should, among other things, step up efforts to correctly inform the government about the Korean pharmaceutical i...
KPMA to hire new vice chairman
The local pharmaceutical industry is paying attention to Korea Pharmaceutical Manufacturers Association’s board of directors who have resumed efforts to find a new vice chairman of the group.
KPMA President Rhu Duk...
Illegal rebate practices are still rampant
It has long been a tough challenge for health authorities to break corrupt ties between drug makers, doctors and pharmacists.
There are still many medical professionals who do not feel compunction about taking reb...
Government to make public new anti-rebate guidelines shortly
The Health Ministry plans to announce its detailed guidelines defining the terms and range of rebate activities in the medical sector, such as payment based financial costs and sponsorship for a seminar, possibly with...
FTC to revise whistle blowers reward plan
The Fair Trade Commission said on July 15 that the government will give whistleblowers rewards for reporting illegal rebate cases involving pharmaceutical firms that have been discovered since May 14 this year.
“W...
KFDA requires additional warning for OTC pain relievers
The Korea Food and Drug Administration has recently issued an additional warning that requires manufacturers of OTC pain relievers and fever reducers to take preventive measures about potential safety risks associated...
Government reaffirms dual punishment on illegal rebate practice
To make the Korean pharmaceutical market more transparent and predictable, the government has recently been stepping up efforts to eliminate the rebate practices.
In an information session on July 13, the Ministry...
